Loading
Our treatments are supported by clinical evidence demonstrating:
Documented Risks: Infection (<2%), mechanical malfunction (1-5% over years), rare complications
Medical therapy should be the first-line treatment. Prosthetic and surgical interventions are indicated when medical therapy provides inadequate response. All treatment selection is guided by patient indication, anatomy, and individual goals.
Regenerative therapies play an adjunctive and supportive role in our protocol, primarily for tissue optimization rather than standalone treatment.
Autologous therapy supporting tissue repair and vascular health.
Adipose-derived and placenta-derived biologics showing promise for tissue regeneration. Research ongoing.
Hormone-like peptides and TRT for hormonal optimization when clinically indicated.
Schedule a confidential consultation to discuss your options.
Schedule Consultation